Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2010

Open Access 01-02-2010 | Research

Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis

Authors: Kevin C Doerschug, Angela S Delsing, Gregory A Schmidt, Alix Ashare

Published in: Critical Care | Issue 1/2010

Login to get access

Abstract

Introduction

Microvascular dysregulation characterized by hyporesponsive vessels and heterogeneous bloodflow is implicated in the pathogenesis of organ failure in sepsis. The renin-angiotensin system (RAS) affects the microvasculature, yet the relationships between RAS and organ injury in clinical sepsis remain unclear. We tested our hypothesis that systemic RAS mediators are associated with dysregulation of the microvasculature and with organ failure in clinical severe sepsis.

Methods

We studied 30 subjects with severe sepsis, and 10 healthy control subjects. Plasma was analyzed for plasma renin activity (PRA) and angiotensin II concentration (Ang II). Using near-infrared spectroscopy, we measured the rate of increase in the oxygen saturation of thenar microvascular hemoglobin after five minutes of induced forearm ischemia. In so doing, we assessed bulk microvascular hemoglobin influx to the tissue during reactive hyperemia. We studied all subjects 24 hours after the development of organ failure. We studied a subset of 12 subjects at an additional timepoint, eight hours after recognition of organ failure (early sepsis).

Results

After 24 hours of resuscitation to clinically-defined endpoints of preload and arterial pressure, Ang II and PRA were elevated in septic subjects and the degree of elevation correlated negatively with the rate of microvascular reoxygenation during reactive hyperemia. Early RAS mediators correlated with microvascular dysfunction. Early Ang II also correlated with the extent of organ failure realized during the first day of sepsis.

Conclusions

RAS is activated in clinical severe sepsis. Systemic RAS mediators correlate with measures of microvascular dysregulation and with organ failure.
Appendix
Available only for authorised users
Literature
1.
Fang X, Tang W, Sun S, Huang L, Chang YT, Castillo C, Weil MH: Comparison of buccal microcirculation between septic and hemorrhagic shock. Crit Care Med 2006, 34: S447-S453. 10.1097/01.CCM.0000246011.86907.3ACrossRefPubMed
2.
Ellis CG, Bateman RM, Sharpe MD, Sibbald WJ, Gill R: Effect of a maldistribution of microvascular blood flow on capillary O(2) extraction in sepsis. Am J Physiol Heart Circ Physiol 2002, 282: H156-164.PubMed
3.
4.
Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004, 32: 1825-1831. 10.1097/01.CCM.0000138558.16257.3FCrossRefPubMed
5.
Tyml K, Yu J, McCormack DG: Capillary and arteriolar responses to local vasodilators are impaired in a rat model of sepsis. J Appl Physiol 1998, 84: 837-844.PubMed
6.
Astiz ME, Tilly E, Rackow ED, Weil MH: Peripheral vascular tone in sepsis. Chest 1991, 99: 1072-1075. 10.1378/chest.99.5.1072CrossRefPubMed
7.
De Blasi RA, Palmisani S, Alampi D, Mercieri M, Romano R, Collini S, Pinto G: Microvascular dysfunction and skeletal muscle oxygenation assessed by phase-modulation near-infrared spectroscopy in patients with septic shock. Intensive Care Med 2005, 31: 1661-1668. 10.1007/s00134-005-2822-yCrossRefPubMed
8.
Skarda DE, Mulier KE, Myers DE, Taylor JH, Beilman GJ: Dynamic near-infrared spectroscopy measurements in patients with severe sepsis. Shock 2007, 27: 348-353. 10.1097/01.shk.0000239779.25775.e4CrossRefPubMed
9.
Doerschug KC, Delsing AS, Schmidt GA, Haynes WG: Impairments in microvascular reactivity are related to organ failure in human sepsis. Am J Physiol Heart Circ Physiol 2007, 293: H1065-1071. 10.1152/ajpheart.01237.2006CrossRefPubMed
10.
Abboud FM: Vascular responses to norepinephrine, angiotensin, vasopressin and serotonin. Fed Proc 1968, 27: 1391-1395.PubMed
11.
Alvarez A, Cerda-Nicolas M, Naim Abu Nabah Y, Mata M, Issekutz AC, Panes J, Lobb RR, Sanz MJ: Direct evidence of leukocyte adhesion in arterioles by angiotensin II. Blood 2004, 104: 402-408. 10.1182/blood-2003-08-2974CrossRefPubMed
12.
Victorino GP, Newton CR, Curran B: Effect of angiotensin II on microvascular permeability. J Surg Res 2002, 104: 77-81. 10.1006/jsre.2002.6412CrossRefPubMed
13.
Bechara RI, Pelaez A, Palacio A, Joshi PC, Hart CM, Brown LA, Raynor R, Guidot DM: Angiotensin II mediates glutathione depletion, transforming growth factor-{beta}1 expression, and epithelial barrier dysfunction in the alcoholic rat lung. Am J Physiol Lung Cell Mol Physiol 2005, 289: L363-370. 10.1152/ajplung.00141.2005CrossRefPubMed
14.
Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM: Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005, 436: 112-116. 10.1038/nature03712CrossRefPubMed
15.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101: 1644-1655. 10.1378/chest.101.6.1644CrossRefPubMed
16.
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31: 1250-1256. 10.1097/01.CCM.0000050454.01978.3BCrossRefPubMed
17.
Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL: Serial evaluation of the SOFA score to predict outcome in critically ill patients. Jama 2001, 286: 1754-1758. 10.1001/jama.286.14.1754CrossRefPubMed
18.
Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 1998, 26: 1793-1800.CrossRefPubMed
19.
Creteur J, Carollo T, Soldati G, Buchele G, De Backer D, Vincent JL: The prognostic value of muscle StO(2) in septic patients. Intensive Care Med 2007, 33: 1549-56. 10.1007/s00134-007-0739-3CrossRefPubMed
20.
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307CrossRefPubMed
21.
Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36: 296-327. 10.1097/01.CCM.0000298158.12101.41CrossRefPubMed
22.
Mancini DM, Bolinger L, Li H, Kendrick K, Chance B, Wilson JR: Validation of near-infrared spectroscopy in humans. J Appl Physiol 1994, 77: 2740-2747.PubMed
23.
Boushel R, Piantadosi CA: Near-infrared spectroscopy for monitoring muscle oxygenation. Acta Physiol Scand 2000, 168: 615-622. 10.1046/j.1365-201x.2000.00713.xCrossRefPubMed
24.
Myers DE, Anderson LD, Seifert RP, Ortner JP, Cooper CE, Beilman GJ, Mowlem JD: Noninvasive method for measuring local hemoglobin oxygen saturation in tissue using wide gap second derivative near-infrared spectroscopy. J Biomed Opt 2005, 10: 034017. 10.1117/1.1925250CrossRefPubMed
25.
Gomez H, Mesquida J, Simon P, Kim H, Puyana J, Ince C, Pinsky M: Characterization of tissue oxygen saturation and the vascular occlusion test: influence of measurement sites, probe sizes and deflation thresholds. Critical Care 2009, 13: S3. 10.1186/cc8001PubMedCentralCrossRefPubMed
26.
Boldt J, Papsdorf M, Kumle B, Piper S, Hempelmann G: Influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill. Crit Care Med 1998, 26: 1663-1670. 10.1097/00003246-199810000-00018CrossRefPubMed
27.
Hilgenfeldt U, Kienapfel G, Kellermann W, Schott R, Schmidt M: Renin-angiotensin system in sepsis. Clin Exp Hypertens A 1987, 9: 1493-1504. 10.3109/10641968709158998PubMed
28.
Dubin A, Pozo MO, Casabella CA, Palizas F Jr, Murias G, Moseinco MC, Kanoore Edul VS, Palizas F, Estenssoro E, Ince C: Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care 2009, 13: R92. 10.1186/cc7922PubMedCentralCrossRefPubMed
29.
Jhanji S, Stirling S, Patel N, Hinds CJ, Pearse RM: The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med 2009, 37: 1961-1966. 10.1097/CCM.0b013e3181a00a1cCrossRefPubMed
30.
Heenen S, De Backer D, Vincent JL: How can the response to volume expansion in patients with spontaneous respiratory movements be predicted? Crit Care 2006, 10: R102. 10.1186/cc4970PubMedCentralCrossRefPubMed
31.
The National Heart L, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network: Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006, 354: 2213-2224. 10.1056/NEJMoa061895CrossRef
32.
Durairaj L, Schmidt GA: Fluid therapy in resuscitated sepsis: less is more. Chest 2008, 133: 252-263. 10.1378/chest.07-1496CrossRefPubMed
33.
Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Kajiyama G, Oshima T: Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function. J Am Coll Cardiol 2001, 37: 863-870. 10.1016/S0735-1097(00)01177-3CrossRefPubMed
34.
Murphey LJ, Morrow JD, Sawathiparnich P, Williams GH, Vaughan DE, Brown NJ: Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensives. Free Radic Biol Med 2003, 35: 711-718. 10.1016/S0891-5849(03)00395-2CrossRefPubMed
35.
De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166: 98-104. 10.1164/rccm.200109-016OCCrossRefPubMed
36.
Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF: Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002, 360: 1395-1396. 10.1016/S0140-6736(02)11393-6CrossRefPubMed
37.
Itoh T, Kajikuri J, Tada T, Suzuki Y, Mabuchi Y: Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries. J Physiol 2003, 548: 893-906. 10.1113/jphysiol.2002.034116PubMedCentralCrossRefPubMed
38.
Oldner A, Wanecek M, Weitzberg E, Rundgren M, Alving K, Ullman J, Rudehill A: Angiotensin II receptor antagonism increases gut oxygen delivery but fails to improve intestinal mucosal acidosis in porcine endotoxin shock. Shock 1999, 11: 127-135. 10.1097/00024382-199902000-00010CrossRefPubMed
39.
Tadros T, Traber DL, Heggers JP, Herndon DN: Angiotensin II inhibitor DuP753 attenuates burn- and endotoxin-induced gut ischemia, lipid peroxidation, mucosal permeability, and bacterial translocation. Ann Surg 2000, 231: 566-576. 10.1097/00000658-200004000-00017PubMedCentralCrossRefPubMed
40.
Mateo T, Abu Nabah YN, Abu Taha M, Mata M, Cerda-Nicolas M, Proudfoot AE, Stahl RA, Issekutz AC, Cortijo J, Morcillo EJ, Jose PJ, Sanz MJ: Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines. J Immunol 2006, 176: 5577-5586.CrossRefPubMed
41.
Pastore L, Tessitore A, Martinotti S, Toniato E, Alesse E, Bravi MC, Ferri C, Desideri G, Gulino A, Santucci A: Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 1999, 100: 1646-1652.CrossRefPubMed
42.
Lund DD, Brooks RM, Faraci FM, Heistad DD: Role of Angiotensin II in Endothelial Dysfunction Induced by Lipopolysaccharide in Mice. Am J Physiol Heart Circ Physiol 2007, 293: H3726-31. 10.1152/ajpheart.01116.2007CrossRefPubMed
43.
Kincaid EH, Miller PR, Meredith JW, Chang MC: Enalaprilat improves gut perfusion in critically injured patients. Shock 1998, 9: 79-83. 10.1097/00024382-199802000-00001CrossRefPubMed
Metadata
Title
Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis
Authors
Kevin C Doerschug
Angela S Delsing
Gregory A Schmidt
Alix Ashare
Publication date
01-02-2010
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2010
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc8887

Other articles of this Issue 1/2010

Critical Care 1/2010 Go to the issue

Commentary

Early vs late start of dialysis: it's all about timing

Research

The use of a blood conservation device to reduce red blood cell transfusion requirements: a before and after study

Commentary

Tracheostomy patients on the ward: multiple benefits from a multidisciplinary team?

Letter

Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis

Commentary

Fluid-induced coagulopathy: does the type of fluid make a difference?

Commentary

Argon neuroprotection